Pilot Randomized Controlled Trial of Mindful Time, a Novel Telehealth Mindfulness-Based Intervention for Autistic Adolescents and Their Caregivers

Saved in:
Bibliographic Details
Title: Pilot Randomized Controlled Trial of Mindful Time, a Novel Telehealth Mindfulness-Based Intervention for Autistic Adolescents and Their Caregivers
Language: English
Authors: Nicole L. Matthews (ORCID 0000-0001-7433-1142), Melissa M. Mitchell, Hannah Honda, Amanda Malligo, Summer Boyd, Broc A. Pagni (ORCID 0000-0002-9496-7604), B. Blair Braden (ORCID 0000-0001-6842-9784)
Source: Autism: The International Journal of Research and Practice. 2025 29(7):1864-1882.
Availability: SAGE Publications. 2455 Teller Road, Thousand Oaks, CA 91320. Tel: 800-818-7243; Tel: 805-499-9774; Fax: 800-583-2665; e-mail: journals@sagepub.com; Web site: https://sagepub.com
Peer Reviewed: Y
Page Count: 19
Publication Date: 2025
Document Type: Journal Articles
Reports - Research
Descriptors: Intervention, Metacognition, Autism Spectrum Disorders, Adolescents, Parents, Program Effectiveness, Depression (Psychology), Gender Differences, Symptoms (Individual Disorders), Parent Child Relationship, Executive Function, Well Being, Mental Health, Emotional Response, Videoconferencing, Anxiety, Telecommunications, Handheld Devices
Geographic Terms: Arizona
Assessment and Survey Identifiers: Kaufman Brief Intelligence Test, Childrens Depression Inventory
DOI: 10.1177/13623613251328484
ISSN: 1362-3613
1461-7005
Abstract: A growing body of research suggests that mindfulness-based interventions may be a valuable method for reducing internalizing symptoms in autistic individuals. The current study extends this work using an effectiveness-implementation hybrid type 1 study. In this parallel randomized controlled trial, we examined a novel telehealth intervention for autistic adolescents and their caregivers. MINDful TIME includes eight weekly group meetings and regular use of a commercially available mindfulness meditation app. Participants were 42 adolescent-parent dyads randomized to the treatment or delayed treatment control (DTC) group. The program was implemented with fidelity (91.24%-94.78%), and 90% of treatment group dyads completed the program. On average, participants attended >90% of sessions and reported high acceptability. Treatment group adolescents demonstrated statistically and clinically significant reductions in parent-reported depression symptoms relative to DTC (F(1, 34) = 7.31, p = 0.01, n[subscript p superscript 2] = 0.18). Female adolescents in the treatment group showed significant reductions in parent-reported anxiety symptoms (F(1, 34) = 4.22, p = 0.05, n[subscript p superscript 2] = 0.11). Exploratory analyses indicated treatment-related improvements in adolescent executive functioning, parent mindfulness and well-being, and adolescent-parent relationship dysfunction. Findings warrant future examination of MINDful TIME to address well-documented challenges with mental health in this population. This trial was registered on clinicaltrials.gov (NCT05685589).
Abstractor: As Provided
Entry Date: 2025
Accession Number: EJ1474950
Database: ERIC
Full text is not displayed to guests.
Description
Abstract:A growing body of research suggests that mindfulness-based interventions may be a valuable method for reducing internalizing symptoms in autistic individuals. The current study extends this work using an effectiveness-implementation hybrid type 1 study. In this parallel randomized controlled trial, we examined a novel telehealth intervention for autistic adolescents and their caregivers. MINDful TIME includes eight weekly group meetings and regular use of a commercially available mindfulness meditation app. Participants were 42 adolescent-parent dyads randomized to the treatment or delayed treatment control (DTC) group. The program was implemented with fidelity (91.24%-94.78%), and 90% of treatment group dyads completed the program. On average, participants attended >90% of sessions and reported high acceptability. Treatment group adolescents demonstrated statistically and clinically significant reductions in parent-reported depression symptoms relative to DTC (F(1, 34) = 7.31, p = 0.01, n[subscript p superscript 2] = 0.18). Female adolescents in the treatment group showed significant reductions in parent-reported anxiety symptoms (F(1, 34) = 4.22, p = 0.05, n[subscript p superscript 2] = 0.11). Exploratory analyses indicated treatment-related improvements in adolescent executive functioning, parent mindfulness and well-being, and adolescent-parent relationship dysfunction. Findings warrant future examination of MINDful TIME to address well-documented challenges with mental health in this population. This trial was registered on clinicaltrials.gov (NCT05685589).
ISSN:1362-3613
1461-7005
DOI:10.1177/13623613251328484